Susan Galandiuk, MD, professor of surgery at the University of Louisville, and her research team have been granted a Clinical and Translational Science Pilot Grant Program’s  Advanced Translational Research Award to develop a “method for the Diagnosis of Inflammatory Bowel Disease-Associated Cancer.”  Galandiuk and her team propose to develop a biomarker signature model using specific blood microRNA biomarkers to help diagnosis cancer in patients with inflammatory bowel disease.  They expect to create a signature model of specific biomarkers that will effectively screen for IBD-associated cancer. This $82,798 award is supported by the Commonwealth of Kentucky-funded Clinical and Translational Science Pilot Grant Program at the University of Louisville.